期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

甲状腺癌分子靶向治疗的现状和前景展望 被引量：6

暂未订购
导出
摘要 分子靶向治疗是指在分子水平上对肿瘤病因学、基因、受体等认识的深入而发展起来的治疗方法。分子靶向药物对甲状腺癌治疗的途径主要包括:VEGFR酪氨酸激酶抑制剂途径;原癌基因RET靶向治疗途径;R-RAF基因靶向治疗途径及EGFR抑制剂途径。甲状腺癌分子靶向治疗发展迅速,靶向治疗药物应用前景广阔,在传统疗法的疗效达到平台时,为甲状腺癌的治疗开辟了新的方向。
作者 刘泽明 李大鹏 黄韬
机构地区 华中科技大学同济医学院附属协和医院乳腺甲状腺外科中心
出处 《中国现代普通外科进展》 CAS 2013年第1期43-46,共4页 Chinese Journal of Current Advances in General Surgery
关键词 甲状腺肿瘤 分子靶向治疗 前景展望
分类号 R736.1 [医药卫生—肿瘤]
  • 相关文献

参考文献20

  • 1Smith NR, Baker D, James NH, et al. Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers [J]. Clin Cancer Res,2010,16 ( 14 ) :3548- 3561.
  • 2Knauf JA, Kuroda H, Basu S, et al. RET/PTC-induced dedifferenti- ation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase[J]. Oncogene,2003,22(28):4406-4412.
  • 3Melillo RM, Castellone MD, Guarino V, et al. The RET/PTC-RAS- BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer ceils [J]. J Clin Invest, 2005,115 (4): 1068-1081.
  • 4Zarebczan B, Chen H. Multi-targeted approach in the treatment of thyroid cancer[J]. Minerva Chir, 2010,65 ( 1 ) :59-69.
  • 5Nucera C, Porrello A, Antonello Z A, et al. B-Raf (V600E) and thrombospondin-1 promote thyroid cancer progression[J]. Proc Natl Acad Sci U S A,2010,107(23):10649-10654.
  • 6Gild ML, Bullock M, Robinson BG, et al. Muhikinase inhibitors: a new option for the treatment of thyroid cancer[J]. Nat Rev Endocrinol, 2011,7(10):617-624.
  • 7Cohen EE, Rosen LS, Vokes EE, et al. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer, results from a phase II study[J]. J Clin Oncol, 2008,26(29):4708-4713.
  • 8Heng DY, Chi KN, Murray N, et al. A population-based study eval- uating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer [J]. Cancer,2009,115 (4): 776-783.
  • 9Torino F, Paragliola RM, Barnabei A, et al. Medullary thyroid can- cer. a promising model for targeted therapy[d-I, Curr Mol Med, 2010,10 (7):608-625.
  • 10Sakurai K, Fukazawa H, Afihara Z, et al. Sunitinib-indueed thyro- toxicosis followed by persistent hypothyroidism with shrinkage of thyroid volume[J]. Tohoku J Exp Med, 2010,222( 1 ):39-44.

同被引文献85

  • 1Hegedüs L. Clinical practice the thyroid nodule[J].New England Journal of Medicine,2004,(17):1764-1771.
  • 2Li Fengzhi,Ambrosini G,Chu E Y. Control of apoptosis and mitotic spindle checkpoint by survivin[J].Nature,1998,(6711):580-584.doi:10.1038/25141.
  • 3Altieri D C. Survivin,versatile modulation of cell division and apoptosis in cancer[J].Oncogene,2003,(53):8581-8589.doi:10.1038/sj.onc.1207113.
  • 4O'Connor D S,Schechner J S,Adida C. Control of apoptosis during angiogenesis by survivin expression in endothelial cells[J].American Journal of Pathology,2000,(02):393-398.
  • 5Hundahl S A,Fleming I D,Fremgen A M. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S.,1985-1995[J].Cancer,1998,(12):2638-2648.doi:10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1.
  • 6Warnecke-Eberz U,Hokita S,Xi Huan. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer[J].Oncology Reports,2005,(06):1241-1246.
  • 7Davies H,Bignell G R,Cox C. Mutations of the BRAF gene in human cancer[J].Nature,2002,(6892):949-954.
  • 8Mercer K E,Pritchard C A. Raf proteins and cancer:BRaf is identified as a mutational target[J].Biochimica Et Biophysica Acta,2003,(01):25-40.
  • 9Kohno M,Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy[J].Annals of Medicine,2006,(03):200-211.doi:10.1080/07853890600551037.
  • 10Alejandro E U,Johnson J D. Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic betacell apoptosis[J].Journal of Biological Chemistry,2008,(04):2407-2417.

引证文献6

二级引证文献15

中国现代普通外科进展
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部